BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®

14 September 2023, Zwingenberg (Germany) - BRAIN Biotech AG today announced that the European Patent Office has issued a new patent covering BRAIN Biotech’s G-dase E® nucleases as a composition of matter patent.